Schering-Plough drug shortages
Executive Summary
CVS reports industry-wide stocking problems with Schering products. The drug chain had shortages for "two [products] from Schering that they just had trouble producing," CEO Tom Ryan reports during a May 2 conference call. One "was an asthma drug, and it has consistently been a problem not only for CVS but the industry. And we had some shortage around some allergy medication with the ramp-up of the allergy season." Schering markets the asthma drugs Proventil and Vanceril and the allergy medications Claritin and Vancenase. Schering has been experiencing manufacturing problems at its facilities (1"The Pink Sheet" March 5, p. 6)